These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14207887)

  • 21. PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM.
    DAVIES GE; LOWE JS
    Br J Pharmacol Chemother; 1963 Dec; 21(3):491-9. PubMed ID: 14110749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Trypsin, chymotrypsin, kallidin and bradykinin].
    WERLE E; KEHL R; KOEBKE K
    Biochem Z; 1950; 321(3):213-20. PubMed ID: 14800984
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kallidin and bradykinin].
    WERLE E
    Arch Int Pharmacodyn Ther; 1953 Jan; 92(3-4):427-31. PubMed ID: 13041308
    [No Abstract]   [Full Text] [Related]  

  • 24. [APNEA AFTER BRADYKININ AND KALLIDIN].
    GJURIS V; HEICKE B; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Aug; 248():540-51. PubMed ID: 14316389
    [No Abstract]   [Full Text] [Related]  

  • 25. [STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P].
    MICHAUD J
    Presse Med (1893); 1964 Oct; 72():2693-8. PubMed ID: 14226744
    [No Abstract]   [Full Text] [Related]  

  • 26. BIOLOGIC ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES. IX. SOLUBLE COMPLEXES OF RABBIT ANTIBODY WITH UNIVALENT AND DIVALENT HAPTENS.
    ISHIZAKA K; ISHIZAKA T; BANOVITZ J
    J Immunol; 1964 Dec; 93():1001-7. PubMed ID: 14241757
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular permeability-increasing action of hypoalbuminemic substance from Ehrlich ascites carcinoma cells.
    Ueki H; Tsunemi S; Kubota Y
    Gan; 1975 Jun; 66(3):237-43. PubMed ID: 241679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.
    RATNOFF OD; MILES AA
    Br J Exp Pathol; 1964 Jun; 45(3):328-45. PubMed ID: 14173175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Increased vascular permeability in acute inflammation].
    Uilkhelm DL
    Patol Fiziol Eksp Ter; 1968; 12(3):3-16. PubMed ID: 4393895
    [No Abstract]   [Full Text] [Related]  

  • 30. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. VI. Isolation and properties of permeability factor and its inhibitor in human plasma.
    MILL PJ; ELDER JM; MILES AA; WILHELM DL
    Br J Exp Pathol; 1958 Aug; 39(4):343-55. PubMed ID: 13572722
    [No Abstract]   [Full Text] [Related]  

  • 31. Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs.
    Kaminishi H; Cho T; Itoh T; Iwata A; Kawasaki K; Hagihara Y; Maeda H
    FEMS Microbiol Lett; 1993 Nov; 114(1):109-14. PubMed ID: 8293953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative influence of the Ca-ionophore A 23187, bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism.
    Seeger W; Neuhof H; Graubert E; Wolf H; Roka L
    Adv Exp Med Biol; 1983; 156():533-51. PubMed ID: 6407283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative study of the effect of bradykinin, kallidin, methionyl-lysyl-badykinin and eledoisin on skin vessel permeability].
    Gaponiuk PIa; Oĭvin VI
    Biull Eksp Biol Med; 1971 Mar; 71(3):57-9. PubMed ID: 5563790
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of enzymes in inflammation].
    Fujii S; Muramatsu M
    Rinsho Byori; 1973 Jan; 21(1):1-10. PubMed ID: 4267648
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of exogenous histamine on the proteolytic activity, level of proteolysis inhibitors and on the state of the kallikrein-kinin system of the blood].
    Bogadel'nikov IV; Protsenko VZ; Spitsyn IF; Kharchenko VZ; Shaevskiĭ DV
    Patol Fiziol Eksp Ter; 1979; (1):51-4. PubMed ID: 311464
    [No Abstract]   [Full Text] [Related]  

  • 37. [EXPERIMENTAL FINDINGS ON THE INHIBITION OF A SUBSTANCE WITH CAPILLARY PERMEABILITY-INCREASING ACTION PRESENT IN THE BLOOD SERUM BY MEANS OF A KALLIKREIN INHIBITOR].
    STANGALINO G; BAGGI GF
    Arch Sci Med (Torino); 1964 Apr; 117():192-8. PubMed ID: 14159282
    [No Abstract]   [Full Text] [Related]  

  • 38. THE EFFECT OF SOME PHYSIOLOGICAL VASODILATORS ON THE VASCULAR BED OF SKELETAL MUSCLE.
    KJELLMER I; ODELRAM H
    Acta Physiol Scand; 1965; 63():94-102. PubMed ID: 14286779
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON THE BIOCHEMISTRY OF PATHOLOGICAL KERATINIZATION, PARTICULARLY IN PSORIASIS. PROTEOLYTIC ACTIVITY ON THE SURFACE OF THE PATHOLOGICALLY CHANGED SKIN].
    STEIGLEDER GK; ENDRES E
    Arch Klin Exp Dermatol; 1964 Jan; 218():105-10. PubMed ID: 14126680
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of some polypeptides and protein derivatives in inflammation].
    Popescu E
    Stud Cercet Med Interna; 1969; 10(1):29-37. PubMed ID: 4241956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.